Thank you.
Ms. Elmslie, you talked about changing over time. The reason we're having this meeting tonight is that there is a simultaneous contradiction in advice, because at about the same time there was Health Canada's summary of the rationale for its February 26 authorization. Just days before NACI said what it said, Health Canada said this: “Efficacy in individuals 65 years of age and older is supported by immunogenicity data, emerging real world evidence and post-market experience in regions where the vaccine has been deployed, which suggest at this point in time a potential benefit and no safety concerns.”
How do you square that? We have NACI telling us there's insufficient evidence of efficacy, and Health Canada, at the very same time, is telling Canadians that efficacy is supported by data. Help me understand that contradiction and whom Canadians should believe.